148 related articles for article (PubMed ID: 31926145)
41. Inhibition of inducible nitric oxide synthase in respiratory diseases.
Hesslinger C; Strub A; Boer R; Ulrich WR; Lehner MD; Braun C
Biochem Soc Trans; 2009 Aug; 37(Pt 4):886-91. PubMed ID: 19614613
[TBL] [Abstract][Full Text] [Related]
42. Withanolides from Physalis peruviana showing nitric oxide inhibitory effects and affinities with iNOS.
Dong B; An L; Yang X; Zhang X; Zhang J; Tuerhong M; Jin DQ; Ohizumi Y; Lee D; Xu J; Guo Y
Bioorg Chem; 2019 Jun; 87():585-593. PubMed ID: 30928880
[TBL] [Abstract][Full Text] [Related]
43. Intracerebroventricular injection of neuronal and inducible nitric oxide synthase inhibitors attenuates fever due to LPS in rats.
Soszynski D; Chelminiak M
J Physiol Pharmacol; 2007 Sep; 58(3):551-61. PubMed ID: 17928650
[TBL] [Abstract][Full Text] [Related]
44. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
Strub A; Ulrich WR; Hesslinger C; Eltze M; Fuchss T; Strassner J; Strand S; Lehner MD; Boer R
Mol Pharmacol; 2006 Jan; 69(1):328-37. PubMed ID: 16223957
[TBL] [Abstract][Full Text] [Related]
45. Targeting iNOS As a Valuable Strategy for the Therapy of Glioma.
Maccallini C; Gallorini M; Cataldi A; Amoroso R
ChemMedChem; 2020 Feb; 15(4):339-344. PubMed ID: 31851765
[TBL] [Abstract][Full Text] [Related]
46. Inducible nitric oxide synthase--time for reappraisal.
Lirk P; Hoffmann G; Rieder J
Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):89-108. PubMed ID: 14561209
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of nitric oxide synthases, but not inducible nitric oxide synthase, selectively worsens left ventricular function after successful resuscitation from cardiac arrest in swine.
Dokken BB; Gaballa MA; Hilwig RW; Berg RA; Kern KB
Acad Emerg Med; 2015 Feb; 22(2):197-203. PubMed ID: 25639298
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of 4,5-dihydro-1H-pyrazole derivatives as potential nNOS/iNOS selective inhibitors. Part 2: Influence of diverse substituents in both the phenyl moiety and the acyl group.
Carrión MD; Chayah M; Entrena A; López A; Gallo MA; Acuña-Castroviejo D; Camacho ME
Bioorg Med Chem; 2013 Jul; 21(14):4132-42. PubMed ID: 23735830
[TBL] [Abstract][Full Text] [Related]
49. H+-ATPase activity on unilateral ureteral obstruction: interaction of endogenous nitric oxide and angiotensin II.
Valles PG; Manucha WA
Kidney Int; 2000 Oct; 58(4):1641-51. PubMed ID: 11012898
[TBL] [Abstract][Full Text] [Related]
50. The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).
Cheshire DR; Åberg A; Andersson GM; Andrews G; Beaton HG; Birkinshaw TN; Boughton-Smith N; Connolly S; Cook TR; Cooper A; Cooper SL; Cox D; Dixon J; Gensmantel N; Hamley PJ; Harrison R; Hartopp P; Käck H; Leeson PD; Luker T; Mete A; Millichip I; Nicholls DJ; Pimm AD; St-Gallay SA; Wallace AV
Bioorg Med Chem Lett; 2011 Apr; 21(8):2468-71. PubMed ID: 21398123
[TBL] [Abstract][Full Text] [Related]
51. Quinazolinones, Quinazolinthiones, and Quinazolinimines as Nitric Oxide Synthase Inhibitors: Synthetic Study and Biological Evaluation.
Camacho ME; Chayah M; García ME; Fernández-Sáez N; Arias F; Gallo MA; Carrión MD
Arch Pharm (Weinheim); 2016 Aug; 349(8):638-50. PubMed ID: 27328401
[TBL] [Abstract][Full Text] [Related]
52. Cardiovascular responses and neurotransmitter changes during static muscle contraction following blockade of inducible nitric oxide synthase (iNOS) within the ventrolateral medulla.
Ally A; Phattanarudee S; Kabadi S; Patel M; Maher TJ
Brain Res; 2006 May; 1090(1):123-33. PubMed ID: 16650388
[TBL] [Abstract][Full Text] [Related]
53. Effect of cyclosporin A on the expression of inducible nitric oxide synthase in the gingiva of rats.
Gau CH; Chou TC; Chiu HC; Shen EC; Nieh S; Chiang CY; Fu E
J Periodontol; 2005 Dec; 76(12):2260-6. PubMed ID: 16332238
[TBL] [Abstract][Full Text] [Related]
54. The Peptidylarginine Deiminase Inhibitor Cl-Amidine Suppresses Inducible Nitric Oxide Synthase Expression in Dendritic Cells.
Jang B; Ishigami A; Kim YS; Choi EK
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077055
[TBL] [Abstract][Full Text] [Related]
55. KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerization.
Symons KT; Massari ME; Nguyen PM; Lee TT; Roppe J; Bonnefous C; Payne JE; Smith ND; Noble SA; Sablad M; Rozenkrants N; Zhang Y; Rao TS; Shiau AK; Hassig CA
Mol Pharmacol; 2009 Jul; 76(1):153-62. PubMed ID: 19364813
[TBL] [Abstract][Full Text] [Related]
56. Tumor-generated nitric oxide as an antagonist of photodynamic therapy.
Girotti AW
Photochem Photobiol Sci; 2015 Aug; 14(8):1425-32. PubMed ID: 25706541
[TBL] [Abstract][Full Text] [Related]
57. Nitric oxide synthase inhibitor ameliorates oral total parenteral nutrition-induced barrier dysfunction.
Hsu CM; Liu CH; Chen LW
Shock; 2000 Feb; 13(2):135-9. PubMed ID: 10670843
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological evaluation of indazole derivatives.
Claramunt RM; López C; López A; Pérez-Medina C; Pérez-Torralba M; Alkorta I; Elguero J; Escames G; Acuña-Castroviejo D
Eur J Med Chem; 2011 Apr; 46(4):1439-47. PubMed ID: 21334118
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and evaluation of trans 3,4-cyclopropyl L-arginine analogues as isoform selective inhibitors of nitric oxide synthase.
Fishlock D; Perdicakis B; Montgomery HJ; Guillemette JG; Jervis E; Lajoie GA
Bioorg Med Chem; 2003 Mar; 11(6):869-73. PubMed ID: 12614872
[TBL] [Abstract][Full Text] [Related]
60. Role of inducible nitric oxide synthase expressed by alveolar macrophages in high mobility group box 1--induced acute lung injury.
Ren D; Sun R; Wang S
Inflamm Res; 2006 May; 55(5):207-15. PubMed ID: 16830108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
